임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 단계 미표기모집 중단 (진행 중)· Breast CancerA Real-World Study of Clinical Adoption, Treatment Patterns and Tolerability of Adjuvant Ribociclib in HR+/HER2- Early Breast Cancer Patients
리드: 노바티스
- 2상모집 중단 (진행 중)· Lipoprotein DisorderA Study of DII235 in Adults With Elevated Lipoprotein(a)
리드: 노바티스
- 1상모집 중단 (진행 중)· Metastatic Prostate Cancer (mCRPC)A Phase I Study of JSB462 (Luxdegalutamide) in Japanese Patients With Metastatic Prostate Cancer
리드: 노바티스
- 2상모집 중단 (진행 중)· Atopic DermatitisPhase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
리드: 노바티스
- 2상모집 중단 (진행 중)· Metastatic Castration Resistant Prostate Cancer (mCRPC)An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC
리드: 노바티스
- 2상모집 중단 (진행 중)· Ras/MAPK Pathway Vascular Anomalies24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs
협력: 노바티스
- 2상모집 중단 (진행 중)· Prostatic Cancer, Castration-ResistantA Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
리드: 노바티스
- 4상모집 중단 (진행 중)· Primary Open Angle Glaucoma or Ocular HypertensionEffect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT
협력: 노바티스
- 4상모집 중단 (진행 중)· Coronary Heart DiseaseInclisiran Effectiveness in China: a Pragmatic Randomized Trial
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Atherosclerotic Vascular DiseaseInclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
리드: 노바티스
- 1상모집 중단 (진행 중)· Rheumatoid ArthritisAn Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Hemoglobinuria, ParoxysmalPost-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry
리드: 노바티스
- 2상모집 중단 (진행 중)· HypertensionA Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
리드: 노바티스
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
리드: 노바티스
- 3상모집 중단 (진행 중)· Relapsing Multiple Sclerosis (RMS)Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Hidradenitis SuppurativaAssessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.
리드: 노바티스
- 3상모집 중단 (진행 중)· Hidradenitis SuppurativaA Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
리드: 노바티스
- 2상모집 중단 (진행 중)· Idiopathic Inflammatory MyopathiesPhase 2 Study of Rapcabtagene Autoleucel in Myositis
리드: 노바티스
- 4상모집 중단 (진행 중)· Atherosclerotic Cardiovascular DiseaseVictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease
협력: 노바티스
- 4상모집 중단 (진행 중)· Multiple SclerosisConcentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
리드: 노바티스
- 2상모집 중단 (진행 중)· Amyotrophic Lateral Sclerosis (ALS)A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)
리드: 노바티스
- 1상모집 중단 (진행 중)· Systemic Lupus Erythematosus, SLEAn Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Paroxysmal Nocturnal HemoglobinuriaSpecified Drug-use Surveillance of Fabhalta Capsules
리드: 노바티스
- 2상모집 중단 (진행 중)· Endometroid Endometrial CancerA Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
협력: 노바티스
- 2상모집 중단 (진행 중)· Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated VasculitisIptacopan in Patients With ANCA Associated Vasculitis
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Multiple Sclerosis, Relapsing-RemittingITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
리드: 노바티스
- 1상모집 중단 (진행 중)· Metastatic Neuroendocrine Prostate CancerNEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
리드: 노바티스
- 4상모집 중단 (진행 중)· Diabetic Macular EdemaBrolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema
협력: 노바티스
- 3상모집 중단 (진행 중)· Polymyalgia RheumaticaOpen-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Hidradenitis SuppurativaPatient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Chronic Spontaneous UrticariaA Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerLuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
협력: 노바티스
- 1상모집 중단 (진행 중)· Newly Diagnosed and Recurrent GlioblastomaDose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma
리드: 노바티스
- 1상모집 중단 (진행 중)· Sickle Cell DiseaseLong-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
리드: 노바티스
- 2상모집 중단 (진행 중)· Metastatic Castration-Resistant Prostate Cancer (mCRPC)Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Multiple Sclerosis (MS)An Observational Study to Learn About the Interferon-beta Exposure of Pregnant Women During the Second and Third Trimester in Finland and Sweden
협력: 노바티스
- 단계 미표기모집 중단 (진행 중)· Chronic Myeloid LeukemiaAsciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Familial HypercholesterolaemiaSpecified Drug-use Survey of Leqvio for s.c. Injection.
리드: 노바티스
- 2상모집 중단 (진행 중)· Thyroid Eye DiseaseA Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease
리드: 노바티스
- 1상모집 중단 (진행 중)· Mycosis FungoidesTulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
협력: 노바티스
- 2상모집 중단 (진행 중)· Prostatic NeoplasmA Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Moderate-to-severe Plaque PsoriasisSecukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· HR+HER2- Advanced Breast CancerA Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia
리드: 노바티스
- 단계 미표기모집 중단 (진행 중)· Multiple Sclerosis (MS)Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France
리드: 노바티스
- 3상모집 중단 (진행 중)· Chronic Inducible UrticariaA Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines
리드: 노바티스
- 1상모집 중단 (진행 중)· Breast Cancer[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
리드: 노바티스
- 1상모집 중단 (진행 중)· Prostate CancerPhase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT
리드: 노바티스
- 2상모집 중단 (진행 중)· Breast Cancer Stage IVDetection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.